Reckitt Benckiser meets business targets in full-year 2012

Reckitt Benckiser has reported its full-year financial results for 2012, during which it achieved a revenue total of 9.57 billion pounds – up by one percent on 2011.

Its like-for-like growth rate for the year came to five percent, which was well above the market level, with health and hygiene brands such as Durex, Gaviscon, Strepsils, Dettol, Lysol, Harpic and Finish leading this charge.

During the year, Reckitt Benckiser was able to enhanced its focus on its 16 Powermarkets, with many of these being in the emerging market territories that now represent 44 percent of its core net revenue.

Earlier this month, the firm strengthened these efforts further by agreeing a new over-the-counter medication distribution partnership with Bristol-Myers Squibb in Brazil, Mexico and other parts of Latin America.

The firm is now targeting net revenue growth of five to six percent for 2013.

Rakesh Kapoor, chief executive officer, said: "We are laying the foundations for Reckitt Benckiser to succeed in a world where health and hygiene play an increasingly important role in terms of both economic and social development."